Skip to content

PTSD: all studies

Page 45 of 210: studies 441 to 450 of 2,096, newest first. Back to the PTSD overview

Research

Levels of emotional exhaustion and its relationship with depression and posttraumatic stress disorder in ICU nurses: the moderating effect of mindfulness

Di-san junyi daxue xuebao June 18, 2021 LU Fang, XU Yuanyuan, YU Yongju et al.

Objective To investigate the level of emotional exhaustion and its relationship with depression and posttraumatic stress disorder symptoms in intensive care unit (ICU) nurses and explore the moderating effects of mindfulness. Methods From March, 2016 to April 2017, we conducted a survey of the levels of emotional exhaustion, mindfulness, depression and posttraumatic stress disorder among 500...

DOI: 10.16016/j.1000-5404.201901097 (opens in new tab) Full text (opens in new tab) Mindfulness Emotional exhaustion Depressive symptom Posttraumatic stress disorder +2

Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA Sequencing

Research Square June 15, 2021 Dennis Parker Kelley, Katy Venable, Gerald Billac et al. 1 citation preprint

Abstract Post-traumatic stress disorder (PTSD) is associated with cognitive deficits, oxidative stress and inflammation. N,N-dimethyltryptamine (DMT) is a known neuroprotective, antioxidant, anti-inflammatory, and psychoplastogen with antidepressant effects. Therefore, we tested the capacity of DMT, the monoamine oxidase inhibitor (MAOI) harmaline, and “pharmahuasca” (DMT + harmaline) to reduce...

DOI: 10.21203/rs.3.rs-602961/v1 (opens in new tab) Full text (opens in new tab) Harmaline Oxidative stress Neuroprotection Pharmacology +5

Ketamine for the multivariate effect of PTSD: Systematic review and meta-analysis

medRxiv Preprint Server June 13, 2021 Rui Du, Kun Niu, Guofang Lu et al. preprint

The aim of this systematic review and meta-analysis was to examine the efficacy, anti-effect of ketamine (intervention) for post-traumatic stress disorder (PTSD) patients during analgesia proceeding and mental illness treatment methods, in comparison with control (midazolam, opioid, saline or placebo). The bibliographic databases Cochrane, Embase, Pubmed and Web of Science were searched from...

Written exposure therapy and app-delivered mindfulness-based meditation for PTSD and subthreshold PTSD in China: Design of a randomized controlled trial.

Contemporary Clinical Trials Communications June 2021 Muyang Li, Bingsu Wang, Qiang Chen et al.

Posttraumatic stress disorder (PTSD) and subthreshold PTSD are still major global concerns, especially in developing areas short of mental health resources. Written exposure therapy (WET), a brief 5-session treatment, has been found to be effective in reducing PTSD symptoms, but no studies have examined it in an Eastern context. Mindfulness-based meditation mobile application may be a promising...

DOI: 10.1016/j.conctc.2021.100729 (opens in new tab) Full text (opens in new tab) Chinese Gq-5, gratitude questionnaire-5 Hpa-axis, hypothalamic–pituitary–adrenal axis Mba, mindfulness-based application +9

Lucid Dreams in Veterans With Posttraumatic Stress Disorder Include Nightmares

Dreaming June 1, 2021 K. Miller, R. Ross, Gerlinde C. Harb

A previous study in military veterans with posttraumatic stress disorder (PTSD) and recurrent nightmares found a high prevalence of lucid dreaming (LD), the awareness while a dream continues that one is dreaming, and an “LD profile” characterized by frequent dream awareness and rare dream content control. Given the importance of the nightmare disturbance in PTSD, this study assessed with...

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Nature Medicine June 1, 2021 Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein et al. 965 citations

Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with...

DOI: 10.1038/s41591-021-01336-3 (opens in new tab) Full text (opens in new tab) PTSD Treatment MDMA Therapy Clinical trials Mental health breakthrough

Lucid Dreams in Veterans With Posttraumatic Stress Disorder Include Nightmares.

Dreaming June 1, 2021 Katherine E Miller, Richard J Ross, Gerlinde C. Harb

A previous study in military veterans with posttraumatic stress disorder (PTSD) and recurrent nightmares found a high prevalence of lucid dreaming (LD), the awareness while a dream continues that one is dreaming, and an "LD profile" characterized by frequent dream awareness and rare dream content control. Given the importance of the nightmare disturbance in PTSD, this study assessed with...

Military-related posttraumatic stress disorder and mindfulness meditation: A systematic review and meta-analysis

Chinese journal of traumatology = Zhonghua chuang shang za zhi May 18, 2021 Luna Sun, Jingwen Gu, Lijun Huang et al.

Purpose Posttraumatic stress disorder (PTSD) is a significant global mental health concern, especially in the military. This study aims to estimate the efficacy of mindfulness meditation in the treatment of military-related PTSD, by synthesizing evidences from randomized controlled trials. Methods Five electronic databases (Pubmed, EBSCO Medline, Embase, PsychINFO and Cochrane Library) were...

The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis

Cureus May 17, 2021 Sarah Tedesco, Ganeya Gajaram, Shahzad Chida et al. 31 citations

Background: 3,4-methylenedioxymethamphetamine (MDMA), known recreationally as "Molly" or "Ecstasy", is a triple monoamine reuptake inhibitor. MDMA specifically acts as a weak 5-HT1 and 5-HT2 receptor agonist, targeting 5-HT2A, 5-HT2B, and 5-HT2C receptors. Its potential use for therapeutic purposes with these pharmacological profiles remains a controversial subject. Studies have shown the...